Roivant Sciences (ROIV) Long-Term Investments (2021 - 2026)

Roivant Sciences has reported Long-Term Investments for 6 years, with the latest figure at $408.0 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Investments rose 34.68% year-over-year to $408.0 million; the trailing twelve-month figure through Mar 2026 stood at $408.0 million (up 34.68% YoY), and the FY2026 full-year result was $408.0 million, up 34.68% from the prior year.
• Long-Term Investments for Q1 2026 stood at $408.0 million, down from $433.9 million in the prior quarter.
• The five-year high for Long-Term Investments was $433.9 million in Q4 2025, with the low at $135.9 million in Q4 2023.
• Historically, Long-Term Investments has averaged $226.6 million across 5 years, with a median of $178.6 million in 2023.
• Annual changes were most pronounced in 2024 — Long-Term Investments retreated 28.33% — and 2025, when it soared 166.19%.
• Roivant Sciences' Long-Term Investments stood at $172.5 million in 2022, then decreased by 21.2% to $135.9 million in 2023, then rose by 19.92% to $163.0 million in 2024, then soared by 166.19% to $433.9 million in 2025, then declined by 5.97% to $408.0 million in 2026.
• The last three Long-Term Investments figures came in at $408.0 million (Q1 2026), $433.9 million (Q4 2025), and $412.3 million (Q3 2025), per Business Quant data.